Appetite Suppressants: A Physician's Guide to What Works, What Doesn't, and What's Changed











Appetite Suppressants: A Physician's Guide to What Works, What Doesn't, and What's Changed
By Dr. Onikepe Adegbola, MD PhD
The category of appetite suppressants has undergone a transformation in the past five years that dwarfs anything we've seen in the previous fifty. For decades, "appetite suppressant" meant phentermine, an amphetamine derivative that the FDA approved in 1959. The options were limited, the side effects were significant, and the results were temporary.
Then GLP-1 receptor agonists arrived. And the conversation changed entirely.
Today, appetite suppressants range from over-the-counter supplements with minimal evidence to prescription medications that produce 15–25% total body weight loss in clinical trials. The gap between the best and worst options is enormous. Here's what you need to know to make sense of it all.
Key Takeaways
- GLP-1 receptor agonists (semaglutide, tirzepatide) represent the most effective prescription appetite suppressants ever developed, with weight loss of 15–25%
- Traditional appetite suppressants (phentermine, phentermine/topiramate) still have a role for some patients, particularly when GLP-1 access is limited
- Over-the-counter appetite suppressants have weak evidence and are not regulated to the same standards as prescription medications
- All effective appetite suppressants work by modifying brain signaling — the differences are in which pathways they target and how well they do it
- Nutritional support is essential when using any appetite suppressant, because reduced food intake means reduced nutrient intake
How Appetite Suppressants Work: The Biology
Your appetite is regulated by a complex signaling network between your gut, brain, and adipose tissue. Understanding this system explains why some appetite suppressants work dramatically and others barely move the needle.
The hypothalamus is the central control center. It receives input from multiple hormonal signals:
- Ghrelin — produced by the stomach, signals hunger. Levels rise before meals and drop after eating.
- Leptin — produced by fat cells, signals satiety. In obesity, leptin resistance often develops, blunting its effectiveness.
- GLP-1 — produced by intestinal L-cells after eating, reduces appetite and slows gastric emptying.
- GIP — another incretin hormone that contributes to satiety signaling.
- Insulin — signals energy availability to the brain.
- Peptide YY (PYY) — intestinal hormone that promotes satiety.
Effective appetite suppressants modify one or more of these signaling pathways. The more pathways they engage, and the more powerfully they do it, the greater the appetite suppression. This is why GLP-1 receptor agonists — which affect multiple pathways simultaneously — produce results that older, single-pathway drugs never achieved.
Prescription Appetite Suppressants: What's Available
GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)
These are, by any objective measure, the most effective appetite suppressants available today.
Semaglutide (branded as Wegovy for weight loss, Ozempic for diabetes) works by mimicking and amplifying your body's natural GLP-1 hormone. It suppresses appetite through direct action on brain appetite centers, slows stomach emptying to promote early satiety, and improves insulin sensitivity. Clinical trials show 15–17% average total body weight loss at the 2.4 mg weekly dose.
Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) adds GIP receptor agonism to GLP-1, creating a dual mechanism. The results are even more impressive — 20–26% body weight loss in clinical trials. The addition of GIP appears to enhance the appetite suppression beyond what GLP-1 alone achieves.
The side effects are predominantly gastrointestinal: nausea, diarrhea, constipation, and vomiting, particularly during dose escalation. These typically improve over time, and the dose titration schedule is designed to minimize them.
The downside? Cost and access. Without insurance, these medications run $1,000–$1,400 per month. Insurance coverage is improving but inconsistent. And the supply chain, while better than 2023–2024, still has occasional disruptions.
Phentermine
The original prescription appetite suppressant. Phentermine works as a sympathomimetic amine — it releases norepinephrine and, to a lesser extent, dopamine and serotonin in the hypothalamus. The result is reduced appetite and mild increases in energy expenditure.
Typical weight loss: 5–10% of body weight over 3–6 months. That's modest compared to GLP-1 agonists, but it's real and meaningful for patients who need a starting point.
Phentermine carries limitations. It's approved for short-term use only (typically 12 weeks), though many prescribers use it longer with monitoring. Cardiovascular side effects — elevated heart rate, increased blood pressure — are common and preclude its use in patients with heart disease, uncontrolled hypertension, or hyperthyroidism. The stimulant properties can cause insomnia, anxiety, and jitteriness.
Despite these limitations, phentermine remains the most commonly prescribed weight loss medication in the United States — largely because it's cheap (as low as $10–30/month) and has decades of clinical experience behind it.
Phentermine/Topiramate (Qsymia)
This combination adds topiramate — an anti-seizure medication that also suppresses appetite through mechanisms that aren't entirely understood — to phentermine. The combination produces better results than either drug alone: 8–12% body weight loss in clinical trials.
The topiramate component brings its own side effect profile: cognitive dulling ("brain fog"), tingling in extremities, taste changes, and a rare but serious risk of metabolic acidosis. It's teratogenic (category X), so contraception is mandatory for women of childbearing potential.
Naltrexone/Bupropion (Contrave)
This combines an opioid antagonist with an antidepressant. The mechanism involves the brain's reward pathways — naltrexone blocks the opioid receptor-mediated feedback that normally limits the appetite-reducing effects of bupropion. Weight loss averages 5–8% of body weight.
It's positioned as an option for patients who can't access or tolerate GLP-1 agonists. The appetite suppression is milder, and the side effect profile includes nausea, constipation, headache, and rarely elevated blood pressure.
Orlistat (Xenical, Alli)
Technically, orlistat isn't an appetite suppressant — it blocks fat absorption in the gut by inhibiting pancreatic lipase. But it reduces caloric intake by preventing about 30% of dietary fat from being absorbed. Average weight loss is 3–5%, making it the least effective prescription option.
The side effects are the real issue: oily stools, flatulence with discharge, fecal urgency, and fat-soluble vitamin depletion. Many patients find these side effects unacceptable, and adherence rates are low.
Over-the-Counter Appetite Suppressants
The dietary supplement market is filled with products marketed as appetite suppressants. I want to be straightforward about this category: the evidence base is thin for most of them, and the regulation is minimal.
Supplements that show some appetite-modifying effects in research:
- Glucomannan (konjac fiber): Expands in the stomach and may promote mild satiety. Some clinical evidence supports modest weight loss (1–3 pounds more than placebo over 8–12 weeks). Generally safe.
- Green tea extract (EGCG): Shows small effects on metabolic rate and appetite in some studies. The magnitude is minimal — don't expect noticeable appetite suppression from green tea alone.
- 5-HTP: A serotonin precursor that has shown appetite-reducing effects in small studies. Concerns about serotonin syndrome when combined with SSRIs or other serotonergic medications.
- Caffeine: Mild appetite suppressant effect that is well-documented but temporary and dose-dependent. Tolerance develops rapidly.
- Protein supplements: Not marketed as appetite suppressants, but high-protein intake is one of the most evidence-supported strategies for reducing appetite. Protein stimulates GLP-1 and PYY release, promotes satiety, and preserves muscle mass during weight loss.
The honest assessment: no over-the-counter supplement produces appetite suppression remotely comparable to prescription medications. They may provide modest support as part of a broader weight management strategy, but they're not a substitute for evidence-based medical treatment when it's indicated.
Supporting Your Body While Suppressing Your Appetite
Regardless of which appetite suppressant you use, there's a paradox that doesn't get enough attention: reducing how much you eat also reduces how many nutrients you get.
Patients on GLP-1 medications eating 30–50% fewer calories are also getting 30–50% fewer vitamins, minerals, and amino acids — at a time when their body is undergoing significant metabolic change and needs these nutrients the most. The results of this nutritional gap show up as fatigue, hair loss, muscle weakness, and yes, reduced effectiveness of the weight loss itself.
This is why nutritional support during appetite suppression isn't optional. It's a medical necessity. Casa de Sante GLP-1 supplements address this specifically — low-FODMAP formulations that deliver targeted nutrition for patients on appetite-suppressing medications without adding GI burden. From protein supplementation to maintain muscle mass, to digestive enzymes that improve nutrient absorption from smaller meals, to full-spectrum vitamin and mineral support.
The best appetite suppressant in the world doesn't help if malnutrition undermines the treatment.
Frequently Asked Questions
What is the strongest appetite suppressant?
Based on clinical trial data, tirzepatide (Zepbound/Mounjaro) produces the strongest appetite suppression and weight loss of any currently available medication, with average weight loss of 20–26% of body weight. Semaglutide (Wegovy) is the second most effective at 15–17%. Both are GLP-1 receptor agonists available by prescription only.
Are appetite suppressants safe for long-term use?
GLP-1 receptor agonists have safety data extending 3+ years and are approved for long-term use. Phentermine is technically approved for short-term use only (12 weeks), though longer use is common in clinical practice with monitoring. Safety depends on the specific medication, dose, and individual patient factors. All prescription appetite suppressants require medical supervision.
Do appetite suppressants work without exercise?
Yes, appetite suppressants produce weight loss even without exercise — the clinical trials demonstrate this clearly. However, exercise significantly improves outcomes by preserving muscle mass, improving cardiovascular fitness, and supporting metabolic health. I strongly recommend combining appetite suppression with regular physical activity for the best results.
Can you get appetite suppressants without a prescription?
Over-the-counter supplements marketed as appetite suppressants are available, including glucomannan, green tea extract, and caffeine-based products. However, their effects are dramatically weaker than prescription options. Orlistat (Alli) is available over-the-counter at a lower dose, though it works by blocking fat absorption rather than suppressing appetite directly.
Why do I feel hungrier after stopping appetite suppressants?
When you stop appetite-suppressing medications, the hormonal signals they were modifying return to their previous levels — often with a compensatory overshoot. Ghrelin (hunger hormone) levels tend to increase, while satiety signals weaken. This is why weight regain after discontinuing appetite suppressants is common and reflects biology, not personal failure.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your medication, supplement, or treatment plan. Dr. Onikepe Adegbola is the founder of Casa de Sante and practices at Mochi Health.






